Skip to Content
🌐Ship toSelect country

Stylage Bi-Soft L Lidocaine - 2 x 1,0ml

Stylage Bi-Soft L Lidocaine is the lidocaine-containing version of Stylage Bi-Soft L, sharing the same 24mg/g cross-linked HA plus mannitol formulation for correcting moderate to severe wrinkles in the deep dermis (nasolabial folds, marionette lines, temples, sagging cheeks) and for nose/earlobe reshaping and hand rejuvenation. The added lidocaine improves injection comfort. For use by licensed, trained medical professionals only.

121.00 € 121.00 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand STYLAGE®
SKU A5203 Share
Treatment Areas CheeksCreasesGlabella FoldsMarionette LinesMentolabial foldsMouthNasolabial foldsPerioral folds
Tags Cross-Linked Hyaluronic AcidDeep WrinklesLidocaineMedium Wrinkles

Stylage Bi-Soft L Lidocaine is Laboratoires Vivacy's deep-correction formulation, built on IPN-Like (Interpenetrated Polymer Network) cross-linking technology with mannitol as an antioxidant, pre-mixed with lidocaine for a more comfortable injection experience. It is designed to correct medium to very deep wrinkles and prevent volume loss.

CONCENTRATION

  • Cross-linked hyaluronic acid (IPN-Like technology) + mannitol
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 2 x 1.0ml Syringes

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

Results typically last 9-12 months, depending on individual metabolism.

INDICATIONS

  • Medium to very deep wrinkles
  • Deep nasolabial folds
  • Volume loss

TREATMENT AREAS

  • Nasolabial folds
  • Face, general

Stylage Bi-Soft L Lidocaine is injected into the deep dermis using linear threading or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin